Log In
BCIQ
Print this Print this
 

RTU-1096

  Manage Alerts
Collapse Summary General Information
Company Sucampo Pharmaceuticals Inc.
DescriptionVascular adhesion protein-1 (VAP-1; SSAO) inhibitor
Molecular Target Vascular adhesion protein-1 (VAP-1) (SSAO)
Mechanism of ActionVascular adhesion protein-1 (VAP-1) (SSAO) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$273.9M

$273.9M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/07/2015

$273.9M

$273.9M

0

05/18/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today